COMT Val158Met多态性对中风功能结果和恢复的影响
Jiabin Liang1,2, Mingzhu Xu1,3, Xiaodong Wang1,4
1Stroke Biological Recovery Laboratory, Spaulding Rehabilitation Hospital, Teaching Affiliate of Harvard Medical School, Charlestown, MA, USA.
Neurorehabilitation and neural repair
|May 29, 2025
概括
甲基转移酶 (COMT) Val158Met基因多态性与更好的认知功能和中风恢复结果有关. 具体来说,COMT Met/Met基因型与中风后的认知,理解和表达能力的改善有关.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 康复医学 康复医学 康复医学
背景情况:
- 已知catechol-o-methyltransferase (COMT) 基因,特别是Val158Met单核酸多态 (SNP),可以影响一般认知功能.
- 这种COMT Val158Met SNP在中风恢复中的作用在很大程度上仍未被探索.
- 了解像COMT Val158Met这样的遗传因素可能会为个性化中风康复策略提供见解.
研究的目的:
- 调查COMT Val158Met (rs4680) SNP与中风幸存者的功能结果之间的关联.
- 为了确定特定的COMT基因型是否与认知功能,理解,表达和中风后整体恢复相关.
- 为了评估COMT Val158Met多态化对功能独立性中风后康复的影响.
主要方法:
- 一项回顾性研究分析了570名中风患者的数据,并使用了MGB生物库的基因组数据.
- 为详细分析,选择了164名在斯波尔丁康复医院 (SRH) 接受住院康复的患者.
- 功能独立测量 (FIM) 在入院和出院时进行了评估,使用后勤和线性回归模型来评估COMT Val158Met基因型和功能结果之间的关联,并对共变量进行调整.
主要成果:
- 基因型分析显示,高认知功能结果的患者中,COMT Met/Met基因型的频率更高.
- 在对共变量进行调整后,COMT Met/Met基因型显著与积极的认知结果相关 (P=0.029),包括改善理解 (P=0.013) 和表达 (P=0.007).
- 独立二分化分析显示,COMT Met/Met与理解 (P=0.002),表达 (P=0.03),解决问题 (P=0.02) 和记忆 (P=0.039) 的更好结果有关.
结论:
- 携带COMT Met/Met基因型的中风患者表现出更好的认知功能,理解和表达.
- 该COMT Val158Met多态可能成为预测中风恢复和认知结果的潜在遗传生物标志物.
- 这些发现强调了在制定量身定制的中风康复计划时考虑遗传变异的重要性.
相关概念视频
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...


